Concepedia

Publication | Open Access

CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia

30

Citations

32

References

2021

Year

Abstract

Our findings suggest that CD9 is a new biomarker of AML LSCs and is a promising therapeutic target.

References

YearCitations

Page 1